The Glow Stack Composition & Key Research Facts Total blend weight: 70mg lyophilised powder per vial Components: BPC-157 (pentadecapeptide), TB-500 (Thymosin Beta-4 fragment), GHK-Cu (copper tripeptide-1) Primary research focus: Tissue repair signalling pathways, extracellular matrix biology, collagen synthesis, angiogenesis, fibroblast and keratinocyte biology Pathway coverage: ERK1/2, VEGFR2/PI3K/Akt/eNOS (BPC-157)
Intravenous Dosing Limited studies have evaluated NAD+ for conditions such as Parkinsons Disease
By combining the genomic remodeling power of GHK-Cu with the angiogenic precision of BPC-157 and the cytoskeletal mobility of TB-500, this blend addresses the three pillars of tissue regeneration: Structure, Supply, and Mobility
Who is most at risk for B12-related hearing loss
Here are some common misconceptions I hear from patients and how I address them